For the full year of 2024, the Company expects to report revenue of $72.0 million to $74.0 million, GAAP diluted earnings per share of $1.37 to $1.47, and non-GAAP diluted earnings per share of $1.52 to $1.62.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRMD:
- IRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
- iRadimed management to meet with Lake Street
- Iradimed Advances to Nasdaq Global Market Status
- IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market